•  
  •  
 

Abstract

Introduction. Revascularization results in patients with diabetes mellitus (DM) and coronary artery disease involving 3 vessels (CAD 3VD) undergo coronary artery bypass surgery (CABG) are better compared with those undergo percutaneous coronary intervention (PCI) or medical therapy. However, CABG is not always done despite being recommended in accordance with Syntax Score because some patients unwilling to undergo CABG or PCI . This trial determined whether the choice of revascularization affect 5-years survival. Methods. This was a retrospective cohort study with survival analysis to examine the 5-years survival rate of CAD 3VD DM patients undergoing CABG, PCI, or medical therapy. The study was conducted using secondary data of 126 CAD 3VD DM patients who underwent CABG, PCI, or medical therapy at Cipto Mangunkusumo Hospital in 2006-2007 and followed up to 2011-2012 if there any incident died. Results. Best survival was seen in the CABG group (93.5%). The largest proportion of death occured in the medical therapy group (36.1%). The CABG survival was significantly better than the IKP (p=0.01) and medical therapy (p=0.001). PCI group had better survival than medical therapy (69.5% vs. 63.9%). Although not statistically significant, but the proportion of complaints after revascularization in PCI group were found less than medical therapy group (52% vs. 38%). Syntax score that assesses the complexity of stenosis had a significant association with survival (p 0.039). Conclusions.5-years survival of CAD 3VD DM patients is best obtained in the group that underwent CABG. 5-year survival of CAD 3VD DM patients who underwent PCI better than medical therapy but was not statistically significant. Factor that affect the 5-years survival is the complexity stenosis viewed by the Syntax score.

References

1. Gaziano TA, Gaziano JM. Global burden of cardiovascular disease. In: Libby P, Bonow R, Mann D, Zipes D, Braunwald E, editors. Braunwals's Heart Disease: A Textbook of Cardiovascular Medicine 9th ed. Philadelphia: Elsevier; 2012. p.1-18. 2. WHO. Ischemic heart disease, cause of death 2011 [Internet]. Geneva: World Health Organization; 2006 [cited 2013 Feb 13]. Available from: www.who.int/media centre/factsheets/fs310/en/ index.html 3. Nesto RW. Diabetes and heart disease. In: Libby P, Bonow R, Mann D, Zipes D, Braunwald E, editors. Braunwals's Heart Disease, 8th ed: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier; 2008. p. 1547-60. 4. Avogaro A. Incidence of coronary heart disease in type 2 diabetic men and women, impact of microvascular complications, treatment, and geographic location. Diabetes Care. 2007;30(5):1241–7. 5. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600-6. 6. Neeland IJ, Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, et al. Coronary angiographic scoring system. Am Heart J. 2012;164(4):547-52. 7. Banning AP, Westaby S, Mohr FW, Kappetein AP, Morice MC, Leadley K, et al. Revascularization with cardiac surgery versus paclitaxel-eluting stents in patients with diabetes and metabolics syndrome. 1-year results from the Syntax Study. 58th Annual Scientific; 2009Mar 29-31; Session, Orlando. 8. BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503-15. 9. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219-27. 10. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for revascularization in patients with diabetes. N Engl J Med. 2012; 365(25):2375-84. 11. Morrow DA, Gersh BJ. Chronic coronary artery disease. In: Libby P, Bonow R, Mann D, Zipes, Braunwald E, editors. Braunwals's Heart Diseas: A Textbook of Cardiovascular Medicine. Philadelphia: Elsevier; 2008. p.1353-405 12. Dungan KM, Braithwait SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798-807. 13. Gössl M, Faxon DP, Bell MR, Holmes DR, Gersh BJ. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv. 2012;5(4):597-604. 14. Goldin A, Beckman JA, Schmidt AM, Creage MA. Advanced glycation end products sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597-605. 15. Farooq V, Vergouwe Y, Raber L, Vrancx P, Garcia-Garcia H, Diletti R, et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J. 2012;33(24):3098-104. 16. Maron DJ. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE). Curr Atheroscler Rep. 2000;2(4):290-6. 17. Roffi M, Angiolillo DJ, Kappetein AP. Current concepts on coronary revascularization in diabetic patients. Eur Heart J. 2011;32(22):2748-57. 18. Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, RE Shaw, et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv. 2012;5(4):476-90. 19. Kirtane AJ, Gada H, Bangalore S, Kereiakes D, Stone G. TCT-845 percutaneous coronary intervention is associated with lower mortality compared with optimal medical therapy in patients with stable ischemic heart disease and objective evidence of ischemia or abnormal fractional flow reserve: a meta-analysis of randomized Controlled Trials. J Am Coll Cardiol. 2013;62(18_S1):B255. 20. Roffi M, Angiolillo DJ, Kappetein AP. Current concepts on coronary revascularization in diabetic patients. Eur Heart J. 2011;32(22):2748-57. 21. Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, RE Shaw, et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv.2012;5(4):476-90. 22. Kirtane AJ, Gada H, Bangalore S, Kereiakes D, Stone G. Percutaneous coronary intervention is associated with lower mortality compared with optimal medical therapy in patients with stable ischemic heart disease and objective evidence of ischemia or abnormal fractional flow reserve: a meta-analysis of randomized Controlled Trials. J Am Coll Cardiol. 2013;62(18_S1):B255. 23. Blumenthal RS, Cohn G, Schulman SP. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature. J Am Coll Cardiol. 2000;36(3):668–73. 24. Sastroasmoro S, Aminullah A, Rukman Y, Munasir Z. Variabel dan hubungan antar variabel. Dalam: Sastroasmoro S, Ismael S, editor. Dasar-Dasar Metodologi Penelitian Klinis Ed 2. Jakarta: Sagung Seto; 2002. p.235-38.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.